Further studies are expected to explore the impact of the platform's rapid NGS-based diagnostic capabilities on healthcare-associated infections, infection prevention and control, and outbreak identification and response, among other applications.
"Prominent players in the NGS sample preparation market are Illumina, Inc ... NGS as a Substitute for PCR. NGS has increasingly emerged as a superior alternative to traditional PCR-based testing due to ...Rising Automation in NGS Workflows.
Paragon Genomics has launched its CleanPlex� Pharmacogenomics NGS Panel that delivers a comprehensive, efficient, cost-effective pharmacogenomics solution ... .
The oncoReveal Lymphoid panel interrogates 84 genes of interest, including full coding DNA sequence (CDS) of 29 genes with a single-tube, fully automatable NGS workflow that can be performed by any NGS-equipped molecular laboratory.
is a research-driven global leader in precision oncology, pioneering next-generation sequencing (NGS) technologies to transform cancer detection, diagnosis, and treatment.
is a research-driven global leader in precision oncology, pioneering next-generation sequencing (NGS) technologies to transform cancer detection, diagnosis, and treatment.
Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed ...SAN DIEGO, Nov ... (NASDAQ ... ContinueReading ... Contacts ... .
DNAe's NGS-based diagnostic platform – LiDia-SEQ™ – is the world's first system to fully automate the sample-to-result process within a single device ... The First, NGS-Based Sample-to-Result PlatformCategory.
The oncoReveal® EssentialMPN automation method is designed to prepare up to 96 NGS libraries in a single continuous run. . Key features of this NGS automation method include ... "The oncoReveal NGS ...